Username

Password

Preview

Sign-in free and Explore the Exciting World of BiomedExperts:

Over 1.500.000 Profiles
More than 1.800 Organizations worldwide
State of the Art Network Visualizations

Manage your own Profile
Locate Experts in your Country/Region
Locate Experts in your 1. and 2. Level Network
Connect to Experts Worldwide

NetworkView

Hans Brunner

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Disorders

Chemicals & Drugs

Concepts & Ideas

Procedures

Double-Blind Method

Sign-in to see full Profile

Sign-in to see all Coauthors

Publications

TOP 3
Hasler Christopher; Nussberger Jürg; Maillard Marc; Forclaz Andrei; Brunner Hans R; Burnier Michel
Sustained 24-hour blockade of the renin-angiotensin system: a high dose of a long-acting blocker is as effective as a lower dose combined with an angiotensin-converting enzyme inhibitor.
Silva Antonio P; Kaufmann Jocelyne E; Vivancos Cécile; Fakan Stanislav; Cavadas Claudia; Shaw Phillip; Brunner Hans R; Vischer Ulrich; Grouzmann Eric
Neuropeptide Y expression, localization and cellular transducing effects in HUVEC.
Brakch Noureddine; Abdel-Sayed Saad; Allemandou Flore; Wang Qing; Aubert Jean F; Brunner Hans R; Nussberger Juerg
Renal endothelin receptor type B upregulation in rats with low or high renin hypertension.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Hans Brunner (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2005: Hasler Christopher; Nussberger Jürg; Maillard Marc; Forclaz Andrei; Brunner Hans R; Burnier Michel
Sustained 24-hour blockade of the renin-angiotensin system: a high dose of a long-acting blocker is as effective as a lower dose combined with an angiotensin-converting enzyme inhibitor.
Clinical pharmacology and therapeutics 2005;78(5):501-7.
2005: Silva Antonio P; Kaufmann Jocelyne E; Vivancos Cécile; Fakan Stanislav; Cavadas Claudia; Shaw Phillip; Brunner Hans R; Vischer Ulrich; Grouzmann Eric
Neuropeptide Y expression, localization and cellular transducing effects in HUVEC.
Biology of the cell / under the auspices of the European Cell Biology Organization 2005;97(6):457-67.
2004: Brakch Noureddine; Abdel-Sayed Saad; Allemandou Flore; Wang Qing; Aubert Jean F; Brunner Hans R; Nussberger Juerg
Renal endothelin receptor type B upregulation in rats with low or high renin hypertension.
Journal of hypertension 2004;22(9):1797-803.
2004: Mazzolai Lucia; Duchosal Michel A; Korber Martine; Bouzourene Karima; Aubert Jean François; Hao Hiroyuki; Vallet Veronique; Brunner Hans-R; Nussberger Jürg; Gabbiani Giulio; Hayoz Daniel
Endogenous angiotensin II induces atherosclerotic plaque vulnerability and elicits a Th1 response in ApoE-/- mice.
Hypertension 2004;44(3):277-82.
2004: Zanchi Anne; Chiolero Arnaud; Maillard Marc; Nussberger Jürg; Brunner Hans-Rudolf; Burnier Michel
Effects of the peroxisomal proliferator-activated receptor-gamma agonist pioglitazone on renal and hormonal responses to salt in healthy men.
The Journal of clinical endocrinology and metabolism 2004;89(3):1140-5.
2004: Wang Qing; Brunner Hans R; Burnier Michel
Determination of cardiac contractility in awake unsedated mice with a fluid-filled catheter.
American journal of physiology. Heart and circulatory physiology 2004;286(2):H806-14.
2004: Wuerzner Grégoire; Chioléro Arnaud; Maillard Marc; Nussberger Jürg; Brunner Hans R; Burnier Michel;
Angiotensin II receptor blockade prevents acute renal sodium retention induced by low levels of orthostatic stress.
Kidney international 2004;65(1):238-44.
2004: Brunner Hans R
Clinical efficacy and tolerability of olmesartan.
Clinical therapeutics 2004;26 Suppl A():A28-32.
2003: Abdel-Sayed Saad; Brunner Hans Rudolf; Nussberger Juerg
Volume expansion enhances plasma endothelin-1.
American journal of hypertension 2003;16(12):1057-61.
2003: Silva Antonio P; Cavadas Claudia; Baïsse-Agushi Bénédicte; Spertini Olivier; Brunner Hans R; Grouzmann Eric
NPY, NPY receptors, and DPP IV activity are modulated by LPS, TNF-alpha and IFN-gamma in HUVEC.
Regulatory peptides 2003;116(1-3):71-9.
2003: Grouzmann Eric; Cavadas Claudia; Grand Daniela; Moratel Martine; Aubert Jean-François; Brunner Hans R; Mazzolai Lucia
Blood sampling methodology is crucial for precise measurement of plasma catecholamines concentrations in mice.
Pflügers Archiv : European journal of physiology 2003;447(2):254-8.
2003: Abdel-Sayed Saad; Nussberger Juerg; Aubert Jean François; Gohlke Peter; Brunner Hans Rudolf; Brakch Noureddine
Measurement of plasma endothelin-1 in experimental hypertension and in healthy subjects.
American journal of hypertension 2003;16(7):515-21.
2003: Brunner Hans R; Laeis Petra
Clinical efficacy of olmesartan medoxomil.
Journal of hypertension. Supplement : official journal of the International Society of Hypertension 2003;21(2):S43-6.
2003: Burnier Michel; Santschi Valérie; Favrat Bernard; Brunner Hans R
Monitoring compliance in resistant hypertension: an important step in patient management.
Journal of hypertension. Supplement : official journal of the International Society of Hypertension 2003;21(2):S37-42.
2003: Cavadas Claudia; Grand Daniela; Mosimann François; Cotrim Maria Dulce; Fontes Ribeiro Carlos Alberto; Brunner Hans R; Grouzmann Eric
Angiotensin II mediates catecholamine and neuropeptide Y secretion in human adrenal chromaffin cells through the AT1 receptor.
Regulatory peptides 2003;111(1-3):61-5.
2003: Forclaz Andrei; Maillard Marc; Nussberger Jürg; Brunner Hans R; Burnier Michel
Angiotensin II receptor blockade: is there truly a benefit of adding an ACE inhibitor?
Hypertension 2003;41(1):31-6.
2003: Brunner Hans R; Stumpe Klaus O; Januszewicz Andrzej
Antihypertensive efficacy of olmesartan medoxomil and candesartan cilexetil assessed by 24-hour ambulatory blood pressure monitoring in patients with essential hypertension.
Clinical drug investigation 2003;23(7):419-30.
2003: Mattart Mélanie; Mazzolai Lucia; Chambaz Céline; Hayoz Daniel; Brunner Hans R; Silacci Paolo
ET-1 and NOS III gene expression regulation by plaque-free and plaque-prone hemodynamic conditions.
Biorheology 2003;40(1-3):289-97.
2002: Cavadas Cláudia; Silva António Pedro; Cotrim Maria Dulce; Ribeiro Carlos Alberto Fontes; Brunner Hans R; Grouzmann Eric
Differential secretion of catecholamine and neuropeptide Y in response to KCl from mice chromaffin cells.
Annals of the New York Academy of Sciences 2002;971():335-7.
2002: Cavadas Claudia; Ribeiro Carlos Alberto Fontes; Cotrim Maria dulce; Mosimann Francois; Brunner Hans R; Grouzmann Eric
Catecholamine and neuropeptide Y secretion from human adrenal chromaffin cells: effect of nicotine and KCl.
Annals of the New York Academy of Sciences 2002;971():332-4.
2002: Regamey Frédéric; Maillard Marc; Nussberger Jürg; Brunner Hans R; Burnier Michel
Renal hemodynamic and natriuretic effects of concomitant Angiotensin-converting enzyme and neutral endopeptidase inhibition in men.
Hypertension 2002;40(3):266-72.
2002: Maillard Marc P; Perregaux Christine; Centeno Catherine; Stangier Joachim; Wienen Wolfgang; Brunner Hans-R; Burnier Michel
In vitro and in vivo characterization of the activity of telmisartan: an insurmountable angiotensin II receptor antagonist.
The Journal of pharmacology and experimental therapeutics 2002;302(3):1089-95.
2002: Brakch Noureddine; Allemandou Flore; Cavadas Claudia; Grouzmann Eric; Brunner Hans R
Dibasic cleavage site is required for sorting to the regulated secretory pathway for both pro- and neuropeptide Y.
Journal of neurochemistry 2002;81(6):1166-75.
2002: Wang Qing; Hummler Edith; Nussberger Jürg; Clément Sophie; Gabbiani Giulio; Brunner Hans R; Burnier Michel
Blood pressure, cardiac, and renal responses to salt and deoxycorticosterone acetate in mice: role of Renin genes.
Journal of the American Society of Nephrology : JASN 2002;13(6):1509-16.
2002: Pralong François P; Gonzales Christine; Voirol Marie-Jeanne; Palmiter Richard D; Brunner Hans-R; Gaillard Rolf C; Seydoux Josiane; Pedrazzini Thierry
The neuropeptide Y Y1 receptor regulates leptin-mediated control of energy homeostasis and reproductive functions.
The FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2002;16(7):712-4.
2002: Brunner Hans R
The new oral angiotensin II antagonist olmesartan medoxomil: a concise overview.
Journal of human hypertension 2002;16 Suppl 2():S13-6.
2002: Brunner Hans R; Gavras Haralambos
Angiotensin blockade for hypertension: a promise fulfilled.
Lancet 2002;359(9311):990-2.
2002: Maillard Marc P; Würzner Grégoire; Nussberger Jürg; Centeno Catherine; Burnier Michel; Brunner Hans R
Comparative angiotensin II receptor blockade in healthy volunteers: the importance of dosing.
Clinical pharmacology and therapeutics 2002;71(1):68-76.
2002: Nussberger Juerg; Wuerzner Grégoire; Jensen Chris; Brunner Hans R
Angiotensin II suppression in humans by the orally active renin inhibitor Aliskiren (SPP100): comparison with enalapril.
Hypertension 2002;39(1):E1-8.
2002: Csajka Chantal; Buclin Thierry; Fattinger Karin; Brunner Hans R; Biollaz Jérôme
Population pharmacokinetic-pharmacodynamic modelling of angiotensin receptor blockade in healthy volunteers.
Clinical pharmacokinetics 2002;41(2):137-52.
2001: Pellieux C; Foletti A; Peduto G; Aubert J F; Nussberger J; Beermann F; Brunner H R; Pedrazzini T
Dilated cardiomyopathy and impaired cardiac hypertrophic response to angiotensin II in mice lacking FGF-2.
The Journal of clinical investigation 2001;108(12):1843-51.
2001: Cavadas C; Silva A P; Mosimann F; Cotrim M D; Ribeiro C A; Brunner H R; Grouzmann E
NPY regulates catecholamine secretion from human adrenal chromaffin cells.
The Journal of clinical endocrinology and metabolism 2001;86(12):5956-63.
2001: Würzner G; Gerster J C; Chiolero A; Maillard M; Fallab-Stubi C L; Brunner H R; Burnier M
Comparative effects of losartan and irbesartan on serum uric acid in hypertensive patients with hyperuricaemia and gout.
Journal of hypertension 2001;19(10):1855-60.
2001: Würzner G; Chiolero A; Maillard M; Nussberger J; Hayoz D; Brunner H R; Burnier M
Renal and neurohormonal responses to increasing levels of lower body negative pressure in men.
Kidney international 2001;60(4):1469-76.
2001: Sieg-Dobrescu D; Burnier M; Hayoz D; Brunner H R; Waeber B
The return of increased blood pressure after discontinuation of antihypertensive treatment is associated with an impaired post-ischemic skin blood flow response.
Journal of hypertension 2001;19(8):1387-92.
2001: Brunner H R; Nussberger J
Relevance of clinical pharmacological models for the evaluation of therapeutic dose range of an AT1-receptor antagonist.
Journal of hypertension. Supplement : official journal of the International Society of Hypertension 2001;19(1):S15-20.
2001: Wang Q; Hummler E; Maillard M; Nussberger J; Rossier B C; Brunner H R; Burnier M
Compensatory up-regulation of angiotensin II subtype 1 receptors in alpha ENaC knockout heterozygous mice.
Kidney international 2001;59(6):2216-21.
2001: Burnier M; Schneider M P; Chioléro A; Stubi C L; Brunner H R
Electronic compliance monitoring in resistant hypertension: the basis for rational therapeutic decisions.
Journal of hypertension 2001;19(2):335-41.
2000: Murat A; Pellieux C; Brunner H R; Pedrazzini T
Calcineurin blockade prevents cardiac mitogen-activated protein kinase activation and hypertrophy in renovascular hypertension.
The Journal of biological chemistry 2000;275(52):40867-73.
2000: Burnier M; Monod M L; Chioléro A; Maillard M; Nussberger J; Brunner H R
Renal sodium handling in acute and chronic salt loading/depletion protocols: the confounding influence of acute water loading.
Journal of hypertension 2000;18(11):1657-64.
2000: Maillard M P; Rossat J; Brunner H R; Burnier M
Tasosartan, enoltasosartan, and angiotensin II receptor blockade: the confounding role of protein binding.
The Journal of pharmacology and experimental therapeutics 2000;295(2):649-54.
2000: Chiolero A; Maillard M; Nussberger J; Brunner H R; Burnier M
Proximal sodium reabsorption: An independent determinant of blood pressure response to salt.
Hypertension 2000;36(4):631-7.
2000: Hayoz D; Bizzini G; Noël B; Depairon M; Burnier M; Fauveau C; Rouillon A; Brouard R; Brunner H R
Effect of SR 49059, a V1a vasopressin receptor antagonist, in Raynaud's phenomenon.
Rheumatology (Oxford, England) 2000;39(10):1132-8.
2000: Pellieux C; Sauthier T; Aubert J F; Brunner H R; Pedrazzini T
Angiotensin II-induced cardiac hypertrophy is associated with different mitogen-activated protein kinase activation in normotensive and hypertensive mice.
Journal of hypertension 2000;18(9):1307-17.
2000: Mazzolai L; Pedrazzini T; Nicoud F; Gabbiani G; Brunner H R; Nussberger J
Increased cardiac angiotensin II levels induce right and left ventricular hypertrophy in normotensive mice.
Hypertension 2000;35(4):985-91.
2000: Maillard M P; Rossat J; Nussberger J; Ramis J; Pontes C; Burnier M; Brunner H R
Pharmacologic profile of UR-7247, an orally active angiotensin II AT1 receptor antagonist, in healthy volunteers. p6.
Journal of cardiovascular pharmacology 2000;35(3):383-9.
2000: Silacci P; Formentin K; Bouzourène K; Daniel F; Brunner H R; Hayoz D
Unidirectional and oscillatory shear stress differentially modulate NOS III gene expression.
Nitric oxide : biology and chemistry / official journal of the Nitric Oxide Society 2000;4(1):47-56.
2000: Burnier M; Brunner H R
Angiotensin II receptor antagonists.
Lancet 2000;355(9204):637-45.
2000: Pellieux C; Sauthier T; Domenighetti A; Marsh D J; Palmiter R D; Brunner H R; Pedrazzini T
Neuropeptide Y (NPY) potentiates phenylephrine-induced mitogen-activated protein kinase activation in primary cardiomyocytes via NPY Y5 receptors.
Proceedings of the National Academy of Sciences of the United States of America 2000;97(4):1595-600.
2000: Wang Q; Horisberger J D; Maillard M; Brunner H R; Rossier B C; Burnier M
Salt- and angiotensin II-dependent variations in amiloride-sensitive rectal potential difference in mice.
Clinical and experimental pharmacology & physiology 2000;27(1-2):60-6.
2000: Rousso P; Buclin T; Nussberger J; Brunner-Ferber F; Brunner H R; Biollaz J
Bioavailability of repeated oral administration of MDL 100,240, a dual inhibitor of angiotensin-converting enzyme and neutral endopeptidase in healthy volunteers.
European journal of clinical pharmacology 2000;55(10):749-54.
1999: Maillard M P; Mazzolai L; Daven V; Centeno C; Nussberger J; Brunner H R; Burnier M
Assessment of angiotensin II receptor blockade in humans using a standardized angiotensin II receptor-binding assay.
American journal of hypertension 1999;12(12 Pt 1-2):1201-8.
1999: Burnier M; Fricker A F; Hayoz D; Nussberger J; Brunner H R
Pharmacokinetic and pharmacodynamic effects of YM087, a combined V1/V2 vasopressin receptor antagonist in normal subjects.
European journal of clinical pharmacology 1999;55(9):633-7.
1999: Rossat J; Maillard M; Nussberger J; Brunner H R; Burnier M
Renal effects of selective cyclooxygenase-2 inhibition in normotensive salt-depleted subjects.
Clinical pharmacology and therapeutics 1999;66(1):76-84.
1999: Burnier M; Brunner H R
Comparative antihypertensive effects of angiotensin II receptor antagonists.
Journal of the American Society of Nephrology : JASN 1999;10 Suppl 12():S278-82.
1999: Rousso P; Buclin T; Nussberger J; Décosterd L A; La Roche S D; Brunner-Ferber F; Brunner H R; Biollaz J
Effects of a dual inhibitor of angiotensin converting enzyme and neutral endopeptidase, MDL 100,240, on endocrine and renal functions in healthy volunteers.
Journal of hypertension 1999;17(3):427-37.
1999: Mazzolai L; Maillard M; Rossat J; Nussberger J; Brunner H R; Burnier M
Angiotensin II receptor blockade in normotensive subjects: A direct comparison of three AT1 receptor antagonists.
Hypertension 1999;33(3):850-5.
1998: Fricker A F; Nussberger J; Meilenbrock S; Brunner H R; Burnier M
Effect of indomethacin on the renal response to angiotensin II receptor blockade in healthy subjects.
Kidney international 1998;54(6):2089-97.
1998: Burnier M; Brunner H R
Angiotensin II receptor antagonists in hypertension.
Kidney international. Supplement 1998;68():S107-11.
1998: Rutschmann B; Evequoz D; Aubert J F; Brunner H R; Waeber B
Vasopressin dilates the rat carotid artery by stimulating V1 receptors.
Journal of cardiovascular pharmacology 1998;32(4):637-41.
1998: Pechère-Bertschi A; Nussberger J; Biollaz J; Fahti M; Grouzmann E; Morgan T; Brunner H R; Burnier M
Circadian variations of renal sodium handling in patients with orthostatic hypotension.
Kidney international 1998;54(4):1276-82.
1998: Zanchi A; Stergiopulos N; Brunner H R; Hayoz D
Differences in the mechanical properties of the rat carotid artery in vivo, in situ, and in vitro.
Hypertension 1998;32(1):180-5.
1998: Pedrazzini T; Seydoux J; Künstner P; Aubert J F; Grouzmann E; Beermann F; Brunner H R
Cardiovascular response, feeding behavior and locomotor activity in mice lacking the NPY Y1 receptor.
Nature medicine 1998;4(6):722-6.
1998: Mazzolai L; Nussberger J; Aubert J F; Brunner D B; Gabbiani G; Brunner H R; Pedrazzini T
Blood pressure-independent cardiac hypertrophy induced by locally activated renin-angiotensin system.
Hypertension 1998;31(6):1324-30.
1998: Brunner H R
Endothelin inhibition as a biologic target for treating hypertension.
American journal of hypertension 1998;11(4 Pt 3):103S-109S.
1998: Pechère-Bertschi A; Nussberger J; Decosterd L; Armagnac C; Sissmann J; Bouroudian M; Brunner H R; Burnier M
Renal response to the angiotensin II receptor subtype 1 antagonist irbesartan versus enalapril in hypertensive patients.
Journal of hypertension 1998;16(3):385-93.
1998: Rousso P; Buclin T; Nussberger J; Brunner-Ferber F; Brunner H R; Biollaz J
Effects of MDL 100,240, a dual inhibitor of angiotensin-converting enzyme and neutral endopeptidase on the vasopressor response to exogenous angiotensin I and angiotensin II challenges in healthy volunteers.
Journal of cardiovascular pharmacology 1998;31(3):408-17.
1998: Hayoz D; Hengstler J; Noel B; Brunner H R
Vasopressin induces opposite changes in blood flow in the skin and the muscular circulation.
Advances in experimental medicine and biology 1998;449():447-9.
1997: Brunner H R
The new angiotensin II receptor antagonist, irbesartan: pharmacokinetic and pharmacodynamic considerations.
American journal of hypertension 1997;10(12 Pt 2):311S-317S.
1997: Zanchi A; Brunner H R; Hayoz D
Age-related changes of the mechanical properties of the carotid artery in spontaneously hypertensive rats.
Journal of hypertension 1997;15(12 Pt 1):1415-22.
1997: Weber R; Pechère-Bertschi A; Hayoz D; Gerc V; Brouard R; Lahmy J P; Brunner H R; Burnier M
Effects of SR 49059, a new orally active and specific vasopressin V1 receptor antagonist, on vasopressin-induced vasoconstriction in humans.
Hypertension 1997;30(5):1121-7.
1997: Waeber B; Brunner H R
[Measurement of blood pressure: best way to assess cardiovascular risk?]
Archives des maladies du coeur et des vaisseaux 1997;90 Spec No 5():11-3.
1997: Waeber B; Brunner H R
Combination antihypertensive therapy: does it have a role in rational therapy?
American journal of hypertension 1997;10(7 Pt 2):131S-137S.
1997: Zanchi A; Wiesel P; Aubert J F; Brunner H R; Hayoz D
Time course changes of the mechanical properties of the carotid artery in renal hypertensive rats.
Hypertension 1997;29(5):1199-203.
1997: Hagmann M; Nussberger J; Naudin R B; Burns T S; Karim A; Waeber B; Brunner H R
SC-52458, an orally active angiotensin II-receptor antagonist: inhibition of blood pressure response to angiotensin II challenges and pharmacokinetics in normal volunteers.
Journal of cardiovascular pharmacology 1997;29(4):444-50.
1997: Waeber B; Brunner H R
Low-dose combinations versus monotherapies in the treatment of hypertension.
Journal of hypertension. Supplement : official journal of the International Society of Hypertension 1997;15(2):S17-20.
1997: Hayoz D; Weber R; Pechère A; Burnier M; Brunner H R
Heterogeneous vascular response to vasopressin: radial artery versus forearm blood flow.
Journal of hypertension 1997;15(1):35-41.
1997: Csajka C; Buclin T; Brunner H R; Biollaz J
Pharmacokinetic-pharmacodynamic profile of angiotensin II receptor antagonists.
Clinical pharmacokinetics 1997;32(1):1-29.
1996: Noël B; Del Re G; Capone P; Brunner H R; Nussberger J
Clinical and hormonal effects of the new angiotensin II receptor antagonist LRB081.
Journal of cardiovascular pharmacology 1996;28(2):252-8.
1996: Waeber B; Brunner H R
Angiotensin II antagonists: a new class of antihypertensive agent.
The British journal of clinical practice 1996;50(5):265-8.
1996: Burnier M; Roch-Ramel F; Brunner H R
Renal effects of angiotensin II receptor blockade in normotensive subjects.
Kidney international 1996;49(6):1787-90.
1996: Weber R; Stergiopulos N; Brunner H R; Hayoz D
Contributions of vascular tone and structure to elastic properties of a medium-sized artery.
Hypertension 1996;27(3 Pt 2):816-22.
1996: Waeber B; Pechere A; Burnier M; Brunner H R
[Diagnosis and treatment of arterial hypertension in the elderly]
Praxis 1996;85(6):150-4.
1996: Brunner H R; Waeber B
Do we need new antihypertensive drugs?
Journal of cardiovascular pharmacology 1996;27 Suppl 3():S1-4.
1996: Evéquoz D; Aubert J F; Nussberger J; Biollaz J; Diezi J; Brunner H R; Waeber B
Effects of neuropeptide Y on intrarenal hemodynamics, plasma renin activity and urinary sodium excretion in rats.
Nephron 1996;73(3):467-72.
1996: Waeber B; Brunner H R
Cardiovascular hypertrophy: role of angiotensin II and bradykinin.
Journal of cardiovascular pharmacology 1996;27 Suppl 2():S36-40.
1995: Zanchi A; Delacrétaz E; Taleb V; Gaillard R; Jeanrenaud B; Brunner H R; Waeber B
Endothelial function of the mesenteric arteriole and mechanical behaviour of the carotid artery in rats with insulin resistance and hypercholesterolaemia.
Journal of hypertension 1995;13(12 Pt 1):1463-70.
1995: Porret C A; Stergiopulos N; Hayoz D; Brunner H R; Meister J J
Simultaneous ipsilateral and contralateral measurements of vasomotion in conduit arteries of human upper limbs.
The American journal of physiology 1995;269(6 Pt 2):H1852-8.
1995: Hayoz D; Weber R; Rutschmann B; Darioli R; Burnier M; Waeber B; Brunner H R
Postischemic blood flow response in hypercholesterolemic patients.
Hypertension 1995;26(3):497-502.
1995: Evéquoz D; Grouzmann E; Nussberger J; Niederberger M; Brunner H R; Waeber B
Beta-adrenoceptor stimulation increases neuropeptide Y release from sympathetic nerves in intact rats.
Regulatory peptides 1995;58(3):163-6.
1995: Waeber B; Brunner H R
Main objectives and new aspects of combination treatment of hypertension.
Journal of hypertension. Supplement : official journal of the International Society of Hypertension 1995;13(2):S15-9.
1995: Delacrétaz E; Zanchi A; Nussberger J; Hayoz D; Aubert J F; Brunner H R; Waeber B
Chronic nitric oxide synthase inhibition and carotid artery distensibility in renal hypertensive rats.
Hypertension 1995;26(2):332-6.
1995: Burnier M; Pechère-Bertschi A; Nussberger J; Waeber B; Brunner H R
Studies of the renal effects of angiotensin II receptor blockade: the confounding factor of acute water loading on the action of vasoactive systems.
American journal of kidney diseases : the official journal of the National Kidney Foundation 1995;26(1):108-15.
1995: Favrat B; Burnier M; Nussberger J; Lecomte J M; Brouard R; Waeber B; Brunner H R
Neutral endopeptidase versus angiotensin converting enzyme inhibition in essential hypertension.
Journal of hypertension 1995;13(7):797-804.
1995: Zanchi A; Aubert J F; Brunner H R; Waeber B
Vascular acetylcholine response during chronic NO synthase inhibition: in vivo versus in vitro.
Cardiovascular research 1995;30(1):122-9.
1995: Achakri H; Stergiopulos N; Hoogerwerf N; Hayoz D; Brunner H R; Meister J J
Intraluminal pressure modulates the magnitude and the frequency of induced vasomotion in rat arteries.
Journal of vascular research 1995;32(4):237-46.
1995: Pedrazzini T; Cousin P; Aubert J F; Brunner H R
Transient inhibition of angiotensinogen production in transgenic mice bearing an antisense angiotensinogen gene.
Kidney international 1995;47(6):1638-46.
1995: Inglessis N; Nussberger J; Hagmann M; Hiesse-Provost O; Insuasty J; Reid J; Ménard J; Brunner H R
Comparison of the angiotensin II antagonist UP269-6 with the angiotensin converting enzyme inhibitor enalapril in normotensive volunteers challenged with angiotensin I.
Journal of cardiovascular pharmacology 1995;25(6):986-93.
1995: Delacrétaz E; de Quay N; Waeber B; Vial Y; Schulz P E; Burnier M; Brunner H R; Bossart H; Schaad N C
Differential nitric oxide synthase activity in human platelets during normal pregnancy and pre-eclampsia.
Clinical science (London, England : 1979) 1995;88(6):607-10.
1995: Zanchi A; Schaad N C; Osterheld M C; Grouzmann E; Nussberger J; Brunner H R; Waeber B
Effects of chronic NO synthase inhibition in rats on renin-angiotensin system and sympathetic nervous system.
The American journal of physiology 1995;268(6 Pt 2):H2267-73.
1995: Burnier M; Hagman M; Nussberger J; Biollaz J; Armagnac C; Brouard R; Weber B; Brunner H R
Short-term and sustained renal effects of angiotensin II receptor blockade in healthy subjects.
Hypertension 1995;25(4 Pt 1):602-9.
1995: Niederberger M; Aubert J F; Nussberger J; Brunner H R; Waeber B
Sympathetic nerve activity in conscious renal hypertensive rats treated with an angiotensin converting enzyme inhibitor or an angiotensin II antagonist.
Journal of hypertension 1995;13(4):439-45.
1995: Hayoz D; Weber R; Delacrétaz E; Brunner H R
[Noninvasive assessment of morphology and function of the great vessels]
Schweizerische medizinische Wochenschrift 1995;125(7):283-7.
1995: Delacrétaz E; Nussberger J; Biollaz J; Waeber B; Brunner H R
Characterization of the angiotensin II receptor antagonist TCV-116 in healthy volunteers.
Hypertension 1995;25(1):14-21.
1995: Hayoz D; Weber R; Brunner H R
Prevention of vascular remodelling in cardiovascular disease.
Cardiology 1995;86 Suppl 1():23-9.
1994: Brunner H R; Nussberger J; Waeber B
Dose-response relationships of ACE inhibitors and angiotensin II blockers.
European heart journal 1994;15 Suppl D():123-8.
1994: Nussberger J; Fleck E; Bahrmann H; Delius W; Schultheiss H P; Brunner H R
Dose-related effects of ACE inhibition in man: quinapril in patients with moderate congestive heart failure. The Study Group on Neurohormonal Regulation in Congestive Heart Failure: Lausanne, Switzerland; Berlin, Düsseldorf, Munich, Germany.
European heart journal 1994;15 Suppl D():113-22.
1994: Brunner H R; Delacrétaz E; Nussberger J; Burnier M; Waeber B
Angiotensin II antagonists DuP 753 and TCV 116.
Journal of hypertension. Supplement : official journal of the International Society of Hypertension 1994;12(9):S29-34.
1994: Pellacani A; Brunner H R; Nussberger J
Plasma kinins increase after angiotensin-converting enzyme inhibition in human subjects.
Clinical science (London, England : 1979) 1994;87(5):567-74.
1994: Evéquoz D; Grouzmann E; Beck-Sickinger A G; Brunner H R; Waeber B
Differential vascular effects of neuropeptide Y(NPY) selective receptor agonists.
Experientia 1994;50(10):936-8.
1994: Burnier M; Brunner H R
Angiotensin II receptor antagonists and the kidney.
Current opinion in nephrology and hypertension 1994;3(5):537-45.
1994: Delacrétaz E; Nussberger J; Püchler K; Wood A J; Robinson P R; Waeber B; Brunner H R
Value of different clinical and biochemical correlates to assess angiotensin converting enzyme inhibition.
Journal of cardiovascular pharmacology 1994;24(3):479-85.
1994: Münzel T; Hayoz D; Hornig B; Kurz S; Just H; Zelis B; Brunner H R; Drexler H
[Increased vascular sensitivity to nitroglycerin in patients with hypercholesterolemia and peripheral endothelial dysfunction]
Deutsche medizinische Wochenschrift (1946) 1994;119(31-32):1065-70.
1994: Waeber B; Burnier M; Heynen G; Brunner H R
Clinical utility of ambulatory blood pressure monitoring in the evaluation of patients with borderline hypertension.
Journal of cardiovascular risk 1994;1(2):120-6.
1994: Zanchi A; Nussberger J; Criscuoli M; Capone P; Brunner H R
Angiotensin-converting enzyme inhibition by hydroxamic zinc-binding idrapril in humans.
Journal of cardiovascular pharmacology 1994;24(2):317-22.
1994: Burnier M; Waeber B; Brunner H R
The advantages of angiotensin II antagonism.
Journal of hypertension. Supplement : official journal of the International Society of Hypertension 1994;12(2):S7-15.
1994: Delacrétaz E; Hayoz D; Osterheld M C; Genton C Y; Brunner H R; Waeber B
Long-term nitric oxide synthase inhibition and distensibility of carotid artery in intact rats.
Hypertension 1994;23(6 Pt 2):967-70.
1994: Burnier M; Centeno G; Burki E; Brunner H R
Confocal microscopy to analyze cytosolic and nuclear calcium in cultured vascular cells.
The American journal of physiology 1994;266(4 Pt 1):C1118-27.
1994: Drexler H; Hayoz D; Münzel T; Just H; Zelis R; Brunner H R
Endothelial dysfunction in chronic heart failure. Experimental and clinical studies.
Arzneimittel-Forschung 1994;44(3A):455-8.
1994: Evequoz D; Burnier M; Niederberger M; Brunner H R; Nussberger J; Waeber B
Mechanisms of the pressor response to intravenous thyrotropin-releasing hormone in the rat.
Clinical and experimental pharmacology & physiology 1994;21(2):93-100.
1994: Grouzmann E; Alvarez-Bolado G; Meyer C; Osterheld M C; Burnier M; Brunner H R; Waeber B
Localization of neuropeptide Y and its C-terminal flanking peptide in human renal tissue.
Peptides 1994;15(8):1377-82.
1993: Waeber B; Brunner H R
Ambulatory blood pressure monitoring to assess antihypertensive therapy in private practice.
Journal of human hypertension 1993;7(6):563-6.
1993: Waeber B; Heynen G; Brunner H R
[The importance of therapy compliance in the treatment of arterial hypertension]
Schweizerische Rundschau für Medizin Praxis = Revue suisse de médecine Praxis 1993;82(48):1387-9.
1993: Brunner H R; Nussberger J; Waeber B
Control of vascular tone by renin and angiotensin in cardiovascular disease.
European heart journal 1993;14 Suppl I():149-53.
1993: Brunner H R; Nussberger J; Burnier M; Waeber B
Angiotensin II antagonists.
Clinical and experimental hypertension (New York, N.Y. : 1993) 1993;15(6):1221-38.
1993: Burnier M; Rutschmann B; Nussberger J; Versaggi J; Shahinfar S; Waeber B; Brunner H R
Salt-dependent renal effects of an angiotensin II antagonist in healthy subjects.
Hypertension 1993;22(3):339-47.
1993: Hayoz D; Rutschmann B; Genton C Y; Niederberger M; Brunner H R; Waeber B
Elastic behaviour of the carotid artery in intact spontaneously hypertensive rats.
European heart journal 1993;14 Suppl C():10-3.
1993: Hayoz D; Tardy Y; Rutschmann B; Mignot J P; Achakri H; Feihl F; Meister J J; Waeber B; Brunner H R
Spontaneous diameter oscillations of the radial artery in humans.
The American journal of physiology 1993;264(6 Pt 2):H2080-4.
1993: Waeber B; Wohler D; Lüscher T F; Schubiger J L; Brunner H R
Antihypertensive efficacy of cilazapril in general practice: assessment by ambulatory blood pressure monitoring.
The American journal of medicine 1993;94(4A):60S-64S.
1993: Porchet M; Nussberger J; Brunner H R; Waeber B
[Blood pressure recording in outpatient service: experience with the Sandoz Pressure System]
Schweizerische Rundschau für Medizin Praxis = Revue suisse de médecine Praxis 1993;82(11):320-2.
1993: Brunner H R; Nussberger J; Waeber B
Inhibitors of the renin-angiotensin system.
Arzneimittel-Forschung 1993;43(2A):274-8.
1993: Walker P; Munoz M; Combe M C; Grouzmann E; Herzog H; Selbie L; Shine J; Brunner H R; Waeber B; Wittek R
High level expression of human neuropeptide Y receptors in mammalian cells infected with a recombinant vaccinia virus.
Molecular and cellular endocrinology 1993;91(1-2):107-12.
1993: Pedrazzini T; Brunner H R; Waeber B
Neuropeptide Y and cardiovascular regulation.
Current opinion in nephrology and hypertension 1993;2(1):106-13.
1993: Brunner H R; Nussberger J; Waeber B
Angiotensin antagonists.
Advances in nephrology from the Necker Hospital 1993;22():305-27.
1993: Hayoz D; Nussberger J; Waeber B; Brunner H R
The renin-angiotensin system and arterial wall behavior.
Journal of cardiovascular pharmacology 1993;22 Suppl 5():S48-52.
1992: Brunner H R; Waeber B; Nussberger J
Strategies for the management of hypertension in aircrew.
European heart journal 1992;13 Suppl H():45-9.
1992: Waeber B; Soret P; Poget P N; Brunner H R
[Evaluation of the antihypertensive efficacy of isradipine SRO as assessed by ambulatory blood pressure determination]
Schweizerische Rundschau für Medizin Praxis = Revue suisse de médecine Praxis 1992;81(50):1514-7.
1992: Burnier M; Brunner H R
Neurohormonal consequences of diuretics in different cardiovascular syndromes.
European heart journal 1992;13 Suppl G():28-33.
1992: Brunner H R; Christen Y; Munafo A; Lee R J; Waeber B; Nussberger J
Clinical experience with angiotensin II receptor antagonists.
American journal of hypertension 1992;5(12 Pt 2):243S-246S.
1992: Grouzmann E; Aubert J F; Waeber B; Brunner H R
A sensitive and specific two-site, sandwich-amplified enzyme immunoassay for neuropeptide Y.
Peptides 1992;13(6):1049-54.
1992: Waeber B; Hayoz D; Evéquoz D; Brunner H R
Arterial compliance and distensibility in spontaneously hypertensive rats.
Journal of hypertension. Supplement : official journal of the International Society of Hypertension 1992;10(6):S79-81.
1992: Zelis R; Hayoz D; Drexler H; Münzel T; Hornig B; Zeiher A M; Just H; Brunner H R
Arterial dilatory reserve in congestive heart failure.
Journal of hypertension. Supplement : official journal of the International Society of Hypertension 1992;10(6):S65-7.
1992: Hayoz D; Tardy Y; Rutschmann B; Waeber B; Meister J J; Brunner H R
Effect of mental stress on the tone of a medium-sized muscular artery.
Journal of hypertension. Supplement : official journal of the International Society of Hypertension 1992;10(6):S57-9.
1992: Meister J J; Tardy Y; Stergiopulos N; Hayoz D; Brunner H R; Etienne J D
Non-invasive method for the assessment of non-linear elastic properties and stress of forearm arteries in vivo.
Journal of hypertension. Supplement : official journal of the International Society of Hypertension 1992;10(6):S23-6.
1992: Tardy Y; Hayoz D; Mignot J P; Richard P; Brunner H R; Meister J J
Dynamic non-invasive measurements of arterial diameter and wall thickness.
Journal of hypertension. Supplement : official journal of the International Society of Hypertension 1992;10(6):S105-9.
1992: Brunner H R
ACE inhibitors in renal disease.
Kidney international 1992;42(2):463-79.
1992: Hayoz D; Rutschmann B; Perret F; Niederberger M; Tardy Y; Mooser V; Nussberger J; Waeber B; Brunner H R
Conduit artery compliance and distensibility are not necessarily reduced in hypertension.
Hypertension 1992;20(1):1-6.
1992: Hayoz D; Tardy Y; Perret F; Waeber B; Meister J J; Brunner H R
Non-invasive determination of arterial diameter and distensibility by echo-tracking techniques in hypertension.
Journal of hypertension. Supplement : official journal of the International Society of Hypertension 1992;10(5):S95-100.
1992: Drexler H; Hayoz D; Münzel T; Hornig B; Just H; Brunner H R; Zelis R
Endothelial function in chronic congestive heart failure.
The American journal of cardiology 1992;69(19):1596-601.
1992: Nussberger J; Brunner D; Keller I; Brunner H R
Measurement of converting enzyme activity by antibody-trapping of generated angiotensin II. Comparison with two other methods.
American journal of hypertension 1992;5(6 Pt 1):393-8.
1992: Munafo A; Christen Y; Nussberger J; Shum L Y; Borland R M; Lee R J; Waeber B; Biollaz J; Brunner H R
Drug concentration response relationships in normal volunteers after oral administration of losartan, an angiotensin II receptor antagonist.
Clinical pharmacology and therapeutics 1992;51(5):513-21.
1992: Ganslmayer M; Perret F; Waeber B; Nussberger J; Brunner H R
[Preliminary evaluation of the Profilomat, a new portable blood pressure recorder]
Schweizerische medizinische Wochenschrift 1992;122(15):544-8.
1992: Aubert J F; Walker P; Grouzmann E; Nussberger J; Brunner H R; Waeber B
Inhibitory effect of neuropeptide Y on stimulated renin secretion of awake rats.
Clinical and experimental pharmacology & physiology 1992;19(4):223-8.
1992: Raccaud O; Waeber B; Petrillo A; Wiesel P; Hofstetter J R; Brunner H R
Ambulatory blood pressure monitoring as a means to avoid overtreatment of elderly hypertensive patients.
Gerontology 1992;38(1-2):99-104.
1992: Pellacani A; Brunner H R; Nussberger J
Antagonizing and measurement: approaches to understanding of hemodynamic effects of kinins.
Journal of cardiovascular pharmacology 1992;20 Suppl 9():S28-34.
1991: Niederberger M; Hayoz D; Rutschmann B; Tardy Y; Nussberger J; Waeber B; Brunner H R
Neither hydralazine nor captopril significantly shifts carotid artery distensibility-pressure curves determined in intact spontaneously hypertensive rats.
Journal of hypertension. Supplement : official journal of the International Society of Hypertension 1991;9(6):S404-5.
1991: Nussberger J; Flückiger J P; Hui K Y; Evéquoz D; Waeber B; Brunner H R
Angiotensin I and II disappear completely from circulating blood within 48 hours after binephrectomy: improved measurement of angiotensins in rat plasma.
Journal of hypertension. Supplement : official journal of the International Society of Hypertension 1991;9(6):S230-1.
1991: Waeber B; Rutschmann B; Nüssberger J; Brunner H R
Evaluation of antihypertensive therapy: discrepancies between office and ambulatory recorded blood pressure.
Journal of hypertension. Supplement : official journal of the International Society of Hypertension 1991;9(3):S53-6.
1991: Waeber B; Niederberger M; Nussberger J; Brunner H R
Ambulatory blood pressure monitoring in children, adolescents and elderly people.
Journal of hypertension. Supplement : official journal of the International Society of Hypertension 1991;9(8):S72-4.
1991: Hayoz D; Rutschmann B; Niederberger M; Waeber B; Brunner H R
[Non invasive measurement of arterial compliance]
Archives des maladies du coeur et des vaisseaux 1991;84 Spec No 3():73-6.
1991: Camenzind E; Nussberger J; Juillerat L; Munafo A; Fischli W; Coassolo P; van Brummelen P; Kleinbloesem C H; Waeber B; Brunner H R
Effect of the renin response during renin inhibition: oral Ro 42-5892 in normal humans.
Journal of cardiovascular pharmacology 1991;18(3):299-307.
1991: Burnier M; Ganslmayer M; Perret F; Porchet M; Kosoglou T; Gould A; Nussberger J; Waeber B; Brunner H R
Effects of SCH 34826, an orally active inhibitor of atrial natriuretic peptide degradation, in healthy volunteers.
Clinical pharmacology and therapeutics 1991;50(2):181-91.
1991: Evéquoz D; Reichenstein T; Waeber B; Nussberger J; Brunner H R
[ACE inhibitors in the treatment of hypertension in elderly patients]
Schweizerische Rundschau für Medizin Praxis = Revue suisse de médecine Praxis 1991;80(25):701-6.
1991: Burnier M; Centeno G; Grouzmann E; Walker P; Waeber B; Brunner H R
In vitro effects of DuP 753, a nonpeptide angiotensin II receptor antagonist, on human platelets and rat vascular smooth muscle cells.
American journal of hypertension 1991;4(5 Pt 1):438-43.
1991: Christen Y; Waeber B; Nussberger J; Porchet M; Borland R M; Lee R J; Maggon K; Shum L; Timmermans P B; Brunner H R
Oral administration of DuP 753, a specific angiotensin II receptor antagonist, to normal male volunteers. Inhibition of pressor response to exogenous angiotensin I and II.
Circulation 1991;83(4):1333-42.
1991: Christen Y; Waeber B; Nussberger J; Lee R J; Timmermans P B; Brunner H R
Dose-response relationships following oral administration of DuP 753 to normal humans.
American journal of hypertension 1991;4(4 Pt 2):350S-353S.
1991: Tardy Y; Meister J J; Perret F; Brunner H R; Arditi M
Non-invasive estimate of the mechanical properties of peripheral arteries from ultrasonic and photoplethysmographic measurements.
Clinical physics and physiological measurement : an official journal of the Hospital Physicists' Association, Deutsche Gesellschaft für Medizinische Physik and the European Federation of Organisations for Medical Physics 1991;12(1):39-54.
1991: Scherrer U; Nussberger J; Torriani S; Waeber B; Darioli R; Hofstetter J R; Brunner H R
Effect of weight reduction in moderately overweight patients on recorded ambulatory blood pressure and free cytosolic platelet calcium.
Circulation 1991;83(2):552-8.
1990: Vonmoos S; Nussberger J; Waeber B; Biollaz J; Brunner H R; Leuenberger P
Effect of metoclopramide on angiotensins, aldosterone, and atrial peptide during hypoxia.
Journal of applied physiology (Bethesda, Md. : 1985) 1990;69(6):2072-7.
1990: Brunner H R; Nussberger J; Waeber B
Various approaches to blockade of the renin-angiotensin system: persistent renin response.
Journal of hypertension. Supplement : official journal of the International Society of Hypertension 1990;8(7):S149-53.
1990: Christen Y; Ganslmayer M; Waeber B; Burnier M; Nussberger J; Brunner H R
Use of non-invasive ambulatory blood pressure monitoring to screen for high-risk hypertensive patients.
Journal of hypertension. Supplement : official journal of the International Society of Hypertension 1990;8(6):S119-24.
1990: Juillerat L; Nussberger J; Ménard J; Mooser V; Christen Y; Waeber B; Graf P; Brunner H R
Determinants of angiotensin II generation during converting enzyme inhibition.
Hypertension 1990;16(5):564-72.
1990: Waeber B; Burnier M; Nussberger J; Brunner H R
Trials using a crossover design and ambulatory blood pressure recordings to determine the efficacy of antihypertensive agents in individual patients.
Journal of hypertension. Supplement : official journal of the International Society of Hypertension 1990;8(4):S37-41.
1990: Christen Y; Waeber B; Nussberger J; Brunner H R
Noninvasive blood pressure monitoring at the finger for studying short lasting pressor responses in man.
Journal of clinical pharmacology 1990;30(8):711-4.
1990: Nussberger J; Mooser V; Maridor G; Juillerat L; Waeber B; Brunner H R
Caffeine-induced diuresis and atrial natriuretic peptides.
Journal of cardiovascular pharmacology 1990;15(5):685-91.
1990: Mooser V; Nussberger J; Juillerat L; Burnier M; Waeber B; Bidiville J; Pauly N; Brunner H R
Reactive hyperreninemia is a major determinant of plasma angiotensin II during ACE inhibition.
Journal of cardiovascular pharmacology 1990;15(2):276-82.
1990: Waeber B; Nussberger J; Brunner H R
[Angiotensin-converting-enzyme inhibition in arterial hypertension]
Wiener medizinische Wochenschrift (1946) 1990;140(1-2):22-30.
1990: Waeber B; Evéquoz D; Aubert J F; Flückiger J P; Juillerat L; Nussberger J; Brunner H R
Prevention of renal hypertension in the rat by neuropeptide Y.
Journal of hypertension 1990;8(1):21-5.
1990: Lattion A L; Flückiger J P; Waeber B; Nussberger J; Aubert J F; Brunner H R
Influence of sodium balance on atrial natriuretic factor in rats with one-kidney, one-clip renal hypertension.
Experientia 1990;46(1):69-72.
1990: Waeber B; Nussberger J; Grouzmann E; Burnier M; Brunner H R
Determination of plasma catecholamine and vasoactive peptide concentrations: clinical usefulness.
International journal of radiation applications and instrumentation. Part B, Nuclear medicine and biology 1990;17(7):667-72.
1990: Flückiger J P; Deghenghi R; Waeber B; Immer H U; Nussberger J; Brunner H R
Effects of dextronatrin on blood pressure, hematocrit, urinary sodium excretion and sympathetic nerve activity of rats.
Fundamental & clinical pharmacology 1990;4(2):129-39.
1990: Waeber B; Niederberger M; Gavras H; Nussberger J; Brunner H R
Hemodynamic effects of a kinin antagonist.
Journal of cardiovascular pharmacology 1990;15 Suppl 6():S78-82.
1989: Brunner H R; Waeber B; Nussberger J
Angiotensin-converting enzyme inhibition versus blockade of the renin-angiotensin system.
The American journal of medicine 1989;87(6B):15S-18S.
1989: Burnier M; Waeber B; Nussberger J; Brunner H R
Effect of angiotensin converting enzyme inhibition in renovascular hypertension.
Journal of hypertension. Supplement : official journal of the International Society of Hypertension 1989;7(7):S27-31.
1989: Perret F; Mooser V; Waeber B; Yanik T; Jean-Jacques M; Mooser E; Nussberger J; Brunner H R
Effect of cold pressor test on the internal diameter of the radial artery.
American journal of hypertension 1989;2(9):727-8.
1989: Flückiger J P; Gremaud G; Waeber B; Kulik A; Ichino A; Nussberger J; Brunner H R
Measurement of sympathetic nerve activity in the unanesthetized rat.
Journal of applied physiology (Bethesda, Md. : 1985) 1989;67(1):250-5.
1989: Nussberger J; Delabays A; De Gasparo M; Cumin F; Waeber B; Brunner H R; Ménard J
Hemodynamic and biochemical consequences of renin inhibition by infusion of CGP 38560A in normal volunteers.
Hypertension 1989;13(6 Pt 2):948-53.
1989: Delabays A; Nussberger J; Porchet M; Waeber B; Hoyos P; Boger R; Glassman H; Kleinert H D; Luther R; Brunner H R
Hemodynamic and humoral effects of the new renin inhibitor enalkiren in normal humans.
Hypertension 1989;13(6 Pt 2):941-7.
1989: Waeber B; Burnier M; Perret F; Nussberger J; Brunner H R
Ambulatory blood pressure measurement and antihypertensive therapy.
Journal of hypertension. Supplement : official journal of the International Society of Hypertension 1989;7(3):S33-9.
1989: Waeber B; Nussberger J; Perret L; Santoni J P; Brunner H R
Experience with perindopril in normal volunteers.
Archives des maladies du coeur et des vaisseaux 1989;82 Spec No 1():35-41.
1989: Burnier M; Mooser V; Wauters J P; Marder H K; De Vane P; Nussberger J; Waeber B; Brunner H R
Bolus injections of synthetic atrial natriuretic peptide in patients with chronic renal failure or nephrotic syndrome.
Journal of cardiovascular pharmacology 1989;13(5):682-90.
1989: Nussberger J; Waeber B; Brunner H R
Angiotensin converting enzyme inhibition and renin inhibition.
Journal of hypertension. Supplement : official journal of the International Society of Hypertension 1989;7(2):S75-9.
1989: Nussberger J; Waeber B; Brunner H R
Plasma angiotensin II and the antihypertensive action of angiotensin-converting enzyme inhibition.
American journal of hypertension 1989;2(4):286-93.
1989: Mooser V; Burnier M; Nussberger J; Juillerat L; Waeber B; Brunner H R
Effects of smoking and physical exercise on platelet free cytosolic calcium in healthy normotensive volunteers.
Journal of hypertension 1989;7(3):211-6.
1989: Delabays A; Porchet M; Waeber B; Nussberger J; Brunner H R
Effects of intranasal administration of synthetic (4-28)human atrial natriuretic peptide to normal volunteers.
Journal of cardiovascular pharmacology 1989;13(1):173-6.
1989: Burnier M; Waeber B; Nussberger J; Brunner H R
Pharmacokinetics of angiotensin converting enzyme inhibitors.
British journal of clinical pharmacology 1989;28 Suppl 2():133S-139S; discussion 140S.
1989: Nussberger J; Waeber B; Brunner H R
Clinical pharmacology of ACE inhibition.
Cardiology 1989;76 Suppl 2():11-22.
1989: Waeber B; Juillerat-Jeanneret L; Aubert J F; Schapira M; Nussberger J; Brunner H R
Involvement of the kallikrein-kinin system in the antihypertensive effect of the angiotensin converting enzyme inhibitors.
British journal of clinical pharmacology 1989;27 Suppl 2():175S-180S.
1989: Waeber B; Nussberger J; Perret L; Santoni J P; Brunner H R
Experience with perindopril in normal volunteers.
Clinical and experimental hypertension. Part A, Theory and practice 1989;11 Suppl 2():507-19.
1989: Erard P Y; Gardaz J P; Nussberger J; Livio J J; Waeber B; Brunner H R; Freeman J
[Effects of clonidine on tourniquet-induced systemic arterial hypertension in general anesthesia]
Annales françaises d'anesthèsie et de rèanimation 1989;8 Suppl():R198.
1989: Waeber G; Burnier M; Porchet M; Nussberger J; Waeber B; Brunner H R
Effects of prolonged administration of the angiotensin converting enzyme inhibitor CGS 16617 in normotensive volunteers.
European journal of clinical pharmacology 1989;36(6):587-91.
1989: Burnier M; Mooser V; Nussberger J; Waeber B; Brunner H R
Correlation between plasma concentration of cilazapril and haemodynamic and hormonal effects in healthy man.
British journal of clinical pharmacology 1989;27 Suppl 2():189S-197S.
1989: Waeber B; Nussberger J; Juillerat L; Brunner H R
Angiotensin converting enzyme inhibition: discrepancy between antihypertensive effect and suppression of enzyme activity.
Journal of cardiovascular pharmacology 1989;14 Suppl 4():S53-9.
1988: Nussberger J; Keller I; Waeber B; Brunner H R
Angiotensin II measurement with high-affinity monoclonal antibodies.
Journal of hypertension. Supplement : official journal of the International Society of Hypertension 1988;6(4):S424-5.
1988: Mooser V; Waeber B; Nussberger J; Brunner H R
Antihypertensive effect of diltiazem administered once and twice daily.
Journal of human hypertension 1988;2(4):257-60.
1988: Brunner H R; Waeber B; Nussberger J
What we would like to know about the antihypertensive mechanisms of angiotensin converting enzyme inhibition.
Journal of hypertension. Supplement : official journal of the International Society of Hypertension 1988;6(3):S1-5.
1988: Mimran A; Nussberger J; Ribstein J; Waeber B; Brunner H R
Response of atrial natriuretic peptide to acute saline loading in essential hypertension.
The American journal of physiology 1988;255(6 Pt 2):F1085-90.
1988: Waeber G; Schapira M; Waeber B; Aubert J F; Nussberger J; Brunner H R
Hypotensive effect of the active fragment derived from factor XII is mediated by an activation of the plasma kallikrein-kinin system.
Circulatory shock 1988;26(4):375-82.
1988: Torriani S; Waeber B; Petrillo A; Di Stefano R; Mooser V; Scherrer U; Nussberger J; Hofstetter J R; Brunner H R
Ambulatory blood pressure monitoring in the elderly hypertensive patient.
Journal of hypertension. Supplement : official journal of the International Society of Hypertension 1988;6(1):S25-7.
1988: Waeber B; Aubert J F; Flückiger J P; Nussberger J; Vavrek R J; Stewart J M; Brunner H R
Role of endogenous bradykinin in blood pressure control of conscious rats.
Kidney international. Supplement 1988;26():S63-8.
1988: Brunner H R; Waeber B; Nussberger J
Renin secretion responsiveness: understanding the efficacy of renin-angiotensin inhibition.
Kidney international. Supplement 1988;26():S80-5.
1988: Aubert J F; Waeber B; Rossier B; Geering K; Nussberger J; Brunner H R
Effects of neuropeptide Y on the blood pressure response to various vasoconstrictor agents.
The Journal of pharmacology and experimental therapeutics 1988;246(3):1088-92.
1988: Petrillo A; Scherrer U; Gonvers J J; Nussberger J; Marder H; de Vane P; Waeber B; Hofstetter J R; Brunner H R
Atrial natriuretic peptide administered as intravenous infusion or bolus injection to patients with liver cirrhosis and ascites.
Journal of cardiovascular pharmacology 1988;12(3):279-85.
1988: Lattion A L; Aubert J F; Flückiger J P; Nussberger J; Waeber B; Brunner H R
Effect of sodium intake on gene expression and plasma levels of ANF in rats.
The American journal of physiology 1988;255(2 Pt 2):H245-9.
1988: Waeber B; Aubert J F; Corder R; Evéquoz D; Nussberger J; Gaillard R; Brunner H R
Cardiovascular effects of neuropeptide Y.
American journal of hypertension 1988;1(2):193-9.
1988: Waeber G; Beck G; Waeber B; Bidiville J; Nussberger J; Brunner H R
Comparison of betaxolol with verapamil in hypertensive patients: discrepancy between office and ambulatory blood pressures.
Journal of hypertension 1988;6(3):239-45.
1988: Burnier M; Waeber B; Aubert J F; Nussberger J; Brunner H R
Effects of nonhypotensive endotoxemia in conscious rats: role of prostaglandins.
The American journal of physiology 1988;254(3 Pt 2):H509-16.
1988: Aubert J F; Burnier M; Waeber B; Nussberger J; Dipette D J; Burris J F; Brunner H R
Effects of a nonpressor dose of neuropeptide Y on cardiac output, regional blood flow distribution and plasma renin, vasopressin and catecholamine levels.
The Journal of pharmacology and experimental therapeutics 1988;244(3):1109-15.
1988: Bidiville J; Nussberger J; Waeber G; Porchet M; Waeber B; Brunner H R
Individual responses to converting enzyme inhibitors and calcium antagonists.
Hypertension 1988;11(2):166-73.
1988: Evéquoz D; Waeber B; Aubert J F; Flückiger J P; Nussberger J; Brunner H R
Neuropeptide Y prevents the blood pressure fall induced by endotoxin in conscious rats with adrenal medullectomy.
Circulation research 1988;62(1):25-30.
1988: Aubert J F; Waeber B; Nussberger J; Vavrek R; Stewart J M; Brunner H R
Influence of endogenous bradykinin on acute blood pressure response to vasopressors in normotensive rats assessed with a bradykinin antagonist.
Journal of cardiovascular pharmacology 1988;11(1):51-5.
1988: Bidiville J; Waeber G; Porchet M; Nussberger J; Biollaz J; Gomez H; Callahan L; Waeber B; Brunner H R
Hemodynamic, renal, and endocrine effects of 4-h infusions of human atrial natriuretic peptide in normal volunteers.
Fundamental & clinical pharmacology 1988;2(5):413-29.
1988: Nussberger J; Brunner D B; Waeber B; Brunner H R
In vitro renin inhibition to prevent generation of angiotensins during determination of angiotensin I and II.
Life sciences 1988;42(17):1683-8.
1988: Burgener E; Mooser V; Waeber B; Porchet M; Gardaz J P; Nussberger J; Brunner H R
Calcium entry blockade attenuates the acute blood pressure rise induced by cigarette smoking.
Journal of cardiovascular pharmacology 1988;12 Suppl 6():S126-30.
1988: Goy J J; Waeber B; Nussberger J; Bidiville J; Biollaz J; Nicod P; Mooser V; Kappenberger L; Brunner H R
Infusion of atrial natriuretic peptide to patients with congestive heart failure.
Journal of cardiovascular pharmacology 1988;12(5):562-70.
1988: Flückiger J P; Waeber B; Mimran A; Nussberger J; Wahba W K; Brunner H R
Enhanced urinary kallikrein excretion in response to a moderate sodium load in genetically hypertensive rats.
Journal of cardiovascular pharmacology 1988;12 Suppl 3():S36-42.
1987: Evéquoz D; Waeber B; Corder R; Nussberger J; Gaillard R; Brunner H R
Markedly reduced blood pressure responsiveness in endotoxemic rats; reversal by neuropeptide Y.
Life sciences 1987;41(23):2573-80.
1987: Evéquoz D; Waeber B; Matsueda G; Nussberger J; Brunner H R
Differential blood pressure response to atriopeptin III and sodium nitroprusside in conscious rats with adrenal medullectomy.
European journal of pharmacology 1987;144(2):217-21.
1987: Mooser V; Waeber G; Bidiville J; Waeber B; Nussberger J; Brunner H R
Kalemia during combined therapy with an angiotensin converting enzyme inhibitor and a potassium-sparing diuretic.
Journal of clinical hypertension 1987;3(4):510-3.
1987: Aubert J F; Burnier M; Waeber B; Nussberger J; Brunner H R
Nicotine-induced release of vasopressin in the conscious rat: role of opioid peptides and hemodynamic effects.
The Journal of pharmacology and experimental therapeutics 1987;243(2):681-5.
1987: Schaller M D; Nussberger J; Feihl F; Waeber B; Brunner H R; Perret C; Nicod P
Clinical and hemodynamic correlates of elevated plasma arginine vasopressin after acute myocardial infarction.
The American journal of cardiology 1987;60(14):1178-80.
1987: Biollaz J; Bidiville J; Diézi J; Waeber B; Nussberger J; Brunner-Ferber F; Gomez H J; Brunner H R
Site of the action of a synthetic atrial natriuretic peptide evaluated in humans.
Kidney international 1987;32(4):537-46.
1987: Waeber B; Corder R; Aubert J F; Nussberger J; Gaillard R; Brunner H R
Influence of sodium intake on circulating levels of neuropeptide Y.
Life sciences 1987;41(11):1391-6.
1987: Waeber B; Scherrer U; Petrillo A; Bidiville J; Nussberger J; Waeber G; Hofstetter J R; Brunner H R
Are some hypertensive patients overtreated? A prospective study of ambulatory blood pressure recording.
Lancet 1987;2(8561):732-4.
1987: Waeber B; Aubert J F; Nussberger J; Vavrek R; Stewart J M; Brunner H R
Influence of bradykinin on blood pressure regulation of spontaneously hypertensive rats maintained on different sodium intakes.
Clinical and experimental pharmacology & physiology 1987;14(8):659-64.
1987: Aubert J F; Waeber B; Nussberger J; Vavrek R; Stewart J M; Brunner H R
[Attenuation of the vasopressor effect of angiotensin II, vasopressin and alpha 1-adrenergic stimulation by bradykinin]
Archives des maladies du coeur et des vaisseaux 1987;80(6):832-4.
1987: Aubert J F; Waeber B; Nussberger J; Vavrek R; Stewart J M; Brunner H R
Lack of a role of circulating bradykinin in the blood pressure response to acute angiotensin converting enzyme inhibition in rats.
Agents and actions. Supplements 1987;22():349-54.
1987: Brunner H R; Bidiville J; Waeber G; Porchet M; Nussberger J; Waeber B
Angiotensin-converting enzyme inhibitor versus calcium antagonist in the treatment of hypertension.
Nephron 1987;47 Suppl 1():87-9.
1987: Nussberger J; de Gasparo M; Juillerat L; Guyenne T T; Mooser V; Waeber B; Brunner H R
Rapid measurement of total and active renin: plasma concentrations during acute and sustained converting enzyme inhibition with CGS 14824A.
Clinical and experimental hypertension. Part A, Theory and practice 1987;9(8-9):1353-66.
1987: Brunner H R; Nussberger J; Bidiville J; Waeber G; Porchet M; Waeber B
Acute antihypertensive effect of angiotensin converting enzyme inhibition and calcium entry blockade.
Journal of cardiovascular pharmacology 1987;10 Suppl 10():S87-9.
1987: Kaufmann U; Schapira M; Waeber B; Nussberger J; Brunner H R
Endotoxin-induced hypotension in rats is not mediated by prekallikrein activation.
Circulatory shock 1987;23(3):215-23.

Sign-in to see more

Sign-in free and Explore the Exciting World of BiomedExperts:

NetworkView

Hans Brunner

Research Profile (preview)

Disorders

Chemicals & Drugs

Anatomy

Living Beings

Physiology

Concepts & Ideas

Procedures

Network (preview)

Publications

Sign in free and see...

Visualized networks:

GeoTargeted Searches:

Research Profiles:

Geonetwork of Hans Brunner (preview)

All Publications